Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evidence-based clinical practice guidelines for liver cirrhosis 2015.
Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T. Fukui H, et al. J Gastroenterol. 2016 Jul;51(7):629-50. doi: 10.1007/s00535-016-1216-y. Epub 2016 May 31. J Gastroenterol. 2016. PMID: 27246107 Review.
Open-labeled randomized controlled trial to compare diuretic therapy with recombinant human serum albumin and diuretic therapy for therapeutic treatment of ascites in patients with advanced liver cirrhosis: An exploratory trial.
Nakamura T, Sata M, Suzuki K, Moriwaki H, Fukui H, Fujiyama S, Imawari M. Nakamura T, et al. Among authors: fukui h. Hepatol Res. 2014 May;44(5):502-14. doi: 10.1111/hepr.12142. Epub 2013 May 26. Hepatol Res. 2014. PMID: 23607459
Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
Yoshiji H, Noguchi R, Yamazaki M, Ikenaka Y, Sawai M, Ishikawa M, Kawaratani H, Mashitani T, Kitade M, Kaji K, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Yoshida M, Fukui H. Yoshiji H, et al. Among authors: fukui h. World J Gastroenterol. 2007 Jun 21;13(23):3259-61. doi: 10.3748/wjg.v13.i23.3259. World J Gastroenterol. 2007. PMID: 17589909 Free PMC article.
Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.
Yoshiji H, Noguchi R, Kaji K, Ikenaka Y, Shirai Y, Namisaki T, Kitade M, Tsujimoto T, Kawaratani H, Fukui H. Yoshiji H, et al. Among authors: fukui h. J Gastroenterol. 2010 Apr;45(4):443-50. doi: 10.1007/s00535-009-0158-z. Epub 2009 Nov 26. J Gastroenterol. 2010. PMID: 19941011
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study.
Narahara Y, Kanazawa H, Sakamoto C, Maruyama H, Yokosuka O, Mochida S, Uemura M, Fukui H, Sumino Y, Matsuzaki Y, Masaki N, Kokubu S, Okita K. Narahara Y, et al. Among authors: fukui h. J Gastroenterol. 2012 Mar;47(3):313-20. doi: 10.1007/s00535-011-0485-8. Epub 2011 Oct 25. J Gastroenterol. 2012. PMID: 22038555 Clinical Trial.
Cryptogenic cirrhosis in the region where obesity is not prevalent.
Kojima H, Sakurai S, Matsumura M, Umemoto N, Uemura M, Morimoto H, Tamagawa Y, Fukui H. Kojima H, et al. Among authors: fukui h. World J Gastroenterol. 2006 Apr 7;12(13):2080-5. doi: 10.3748/wjg.v12.i13.2080. World J Gastroenterol. 2006. PMID: 16610061 Free PMC article.
1,455 results